Biotricity Announces Patient Filing for Cutting-Edge Biotres Device
REDWOOD CITY, CA / ACCESSWIRE / October 3, 2023 / Biotricity, Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the...
Day: October 3, 2023
The Immunoglobulin National Society and ACHC Announce Partnership
LOS ANGELES, CA / ACCESSWIRE / October 3, 2023 / Immunoglobulin National Society (IgNS) announced today it is partnering with...
Panoramic Health Appoints Dr. Tarek Elsawy as New CEO
TEMPE, AZ / ACCESSWIRE / October 3, 2023 / Panoramic Health has appointed Dr. Tarek Elsawy as Chief Executive Officer...
The 25 Top Client-Rated Technologies Exhibiting at Becker’s Health IT + Digital Health + RCM Meeting, 2023 Black Book Survey
Black Book Research acknowledges the top-performing healthcare technology companies within various revenue cycle management and digital health market segments based...
Avant Brands Announces Q3 2023 Earnings Conference Call Details
KELOWNA, BC / ACCESSWIRE / October 3, 2023 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer...
Single and Repeat Dose Clinical Study of neffy (epinephrine nasal spray) Published in the Journal of Allergy and Clinical Immunology
Figure 2: Systolic Blood Pressure (SBP) Mean change from baseline in SBP vs time. (A) Single dose. (B) Repeat dose....
Insider information: BBS-Bioactive Bone Substitutes Plc appoints Juliusz Rakowski as new CEO as BBS prepares for the commercial phase
BBS-Bioactive Bone Substitutes Plc, Company Announcement, Insider Information, 3 October 2023 at 4.00 p.m. (EET) Insider information: BBS-Bioactive Bone Substitutes...
Scilex Holding Company Provides Notice to All Record Holders and Beneficial Owners of Restricted Shares of Scilex Holding Company
PALO ALTO, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating...
Certified Testing & Data and Nova Analytic Labs to Launch New York Cannabis Testing Lab
ALBANY, N.Y., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Certified Testing & Data (CTND) and Nova Analytic Labs (Nova) announced a...
NeuroSigma Announces HSA Approval of the Monarch eTNS System in Singapore
LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced approval of the Monarch eTNS System by Singapore’s Health...
Groundbreaking Study Finds Natural Formulation by MDbio – The Doctors BrandTM Significantly Improves Sleep, Anxiety, Stress, and Overall Well-being
Radicle Science studied MDSleep in one of history’s largest clinical trials on a supplement brand’s sleep formulation.Los Angeles, CA, Oct....
Relievant Medsystems Announces Positive Coverage Policy for the Intracept Procedure from Anthem Blue Cross and Blue Shield
Expands access to vertebrogenic pain treatment for 36 million patientsMINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company...
BriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in Advanced Metastatic Breast Cancer
The randomized pivotal Phase 3 study is expected to enroll a total of 354 patients in either Bria-IMT™ combination or...
Cannabix’s MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath
Cannabix Technologies Inc. Cannabix Technologies MSBS and BCU Figures 1 and 2 VANCOUVER, British Columbia, Oct. 03, 2023 (GLOBE NEWSWIRE)...
DiagnaMed Launches New Healthcare Provider Network Program for CERVAI™ Brain Health AI Platform in Canada and the USA
Program provides healthcare providers access to Diagnamed’s novel brain health AI platform Figure 1. Demonstration of CERVAI™ Brain Age™ SessionTORONTO,...
SS Innovations Launches Innovative Robotic Cardiac Surgery Program in India
Dr. Sudhir Srivastava, a world-leading cardiac surgeon, performed the world’s first beating heart robotic cardiac bypass surgery using the SSi...
Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production
Begins revenue generation for “Camelina Seed Genetics to Biofuel” platformWOBURN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc....
Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent...
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
BLOOMFIELD HILLS, Mich, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company...
Kineta Announces Positive KVA12123 Monotherapy Safety and Biomarker Data from its Ongoing Phase 1/2 VISTA-101 Clinical Trial
Cleared First Three Monotherapy Cohorts with No Dose Limiting Toxicity and No Consistent Pattern of Adverse Events at any Dose...